White Paper:

Panel Discussion Summary: The Renaissance of Psychedelics in CNS Medicine

This paper is a written summary of a virtual panel discussion that was held on September 9, 2021 at the MedInvest Neurological Diseases & Mental Health Disorders Conference.  This summary is not a verbatim transcript.  Rather, the speakers’ questions and answers are paraphrased for flow and brevity.  Significant efforts have been made to ensure that the speakers have been summarized accurately, and each speaker has reviewed and approved this summary.

A video of the panel discussion and subsequent question and answer session can be viewed here.


  • Varun Renjen, Associate Principal, Blue Matter Consulting


  • Henri Sant Cassia, Co-Founder and Managing Partner, The Conscious Fund
  • Suran Goonatilake, Ph.D., Co-Founder, April 19 Discovery, Inc.
  • Olivia Mannix, Founder, Chief Strategy Officer, Aphrodite Health
  • James (Jim) Kuo, M.D., M.B.A., Chief Executive Officer, Return Health
  • Hidden
  • This field is for validation purposes and should be left unchanged.